Eur Rev Med Pharmacol Sci 2021; 25 (12): 4188-4189
DOI: 10.26355/eurrev_202106_26120

Comment on “Locally advanced breast implant-associated anaplastic large-cell lymphoma: a combined medical-surgical approach”

E. Cigna, A. Bolletta, L. Domenici, L. Losco

Department of Translational Research and New Technologies in Medicine and Surgery University of Pisa, Italy. emanuele.cigna@unipi.it

Free PDF Download

To cite this article

E. Cigna, A. Bolletta, L. Domenici, L. Losco
Comment on “Locally advanced breast implant-associated anaplastic large-cell lymphoma: a combined medical-surgical approach”

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 12
Pages: 4188-4189
DOI: 10.26355/eurrev_202106_26120

Keywords Related articles:

  1. Locally advanced breast implant-associated anaplastic large-cell lymphoma: a combined medical-surgical approach
  2. Update in the treatment of locally advanced breast cancer: a multidisciplinary approach
  3. Comment on “Predictive value of 18F-FDG PET/CT on survival in locally advanced rectal cancer after neoadjuvant chemoradiation”
  4. Effect of rituximab combined with chemotherapy on the expression of serum exosome miR-451a in patients with diffuse large b-cell lymphoma
  5. Comment on “Tegafur gimeracil oter combined with oxaliplatin for advanced colorectal cancer.” Is it cost effectiveness?